Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMI
826
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $20.9M | 0.03% |
1,132,300
+407,900
| +56% | +$7.29M |
|
|
GCP
827
DELISTED
GCP Applied Technologies Inc.
GCP
| $20.9M | 0.03% |
685,200
-159,300
| -19% | -$5.01M |
|
|
FRP
828
DELISTED
Fairpoint Communications, Inc.
FRP
| $20.9M | 0.03% |
1,334,863
+36,437
| +3% | +$572K |
|
829
Accuray
ARAY
$32.9M
| $20.9M | 0.03% |
4,391,000
+85,400
| +2% | +$375K |
|
|
AHRT
830
AH Realty Trust
AHRT
$501M
| $20.7M | 0.03% |
1,602,000
+104,700
| +7% | +$1.43M |
|
831
FormFactor
FORM
$10.1B
| $20.7M | 0.03% |
1,671,322
+78,868
| +5% | +$1.02M |
|
|
RST
832
DELISTED
ROSETTA STONE INC
RST
| $20.6M | 0.03% |
1,914,400
+42,400
| +2% | +$474K |
|
|
INXN
833
DELISTED
Interxion Holding N.V.
INXN
| $20.6M | 0.03% |
450,700
-16,700
| -4% | -$721K |
|
|
STAY
834
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $20.6M | 0.03% |
1,065,600
-210,800
| -17% | -$3.78M |
|
835
Quaker Houghton
KWR
$2.91B
| $20.6M | 0.03% |
142,000
-12,800
| -8% | -$1.81M |
|
836
Nokia
NOK
$59B
| $20.5M | 0.03% |
3,328,880
+2,915,600
| +705% | +$17.5M |
|
|
LDL
837
DELISTED
Lydall, Inc.
LDL
| $20.5M | 0.03% |
396,600
+800
| +0.2% | +$41.2K |
|
|
IPCC
838
DELISTED
Infinity Property & Casualty C
IPCC
| $20.5M | 0.03% |
218,100
+10,000
| +5% | +$955K |
|
839
Axalta
AXTA
$7.98B
| $20.4M | 0.03% |
637,800
-289,700
| -31% | -$9.25M |
|
840
Central Garden & Pet Co
CENT
$2.79B
| $20.4M | 0.03% |
802,220
+207,095
| +35% | +$5.61M |
|
|
PNK
841
DELISTED
Pinnacle Entertainment Inc.
PNK
| $20.4M | 0.03% |
1,031,300
+796,800
| +340% | +$16M |
|
|
VEDL
842
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $20.3M | 0.03% |
1,307,900
+314,100
| +32% | +$4.7M |
|
843
PJT Partners
PJT
$4.36B
| $20.3M | 0.03% |
503,900
+126,700
| +34% | +$4.74M |
|
|
TTSH
844
DELISTED
Tile Shop Holdings
TTSH
| $20.2M | 0.03% |
980,400
-74,700
| -7% | -$1.52M |
|
845
Western Union
WU
$2.34B
| $20.2M | 0.03% |
1,059,600
-1,288,300
| -55% | -$24.9M |
|
846
A10 Networks
ATEN
$2B
| $20.1M | 0.03% |
2,385,600
+164,900
| +7% | +$1.4M |
|
847
Regis Corp
RGS
$69.3M
| $20.1M | 0.03% |
98,010
+10,135
| +12% | +$2.08M |
|
848
Alliant Energy
LNT
$18.2B
| $20.1M | 0.03% |
500,400
+456,500
| +1,040% | +$18.5M |
|
849
H&R Block
HRB
$6.87B
| $20M | 0.03% |
+645,900
| New | +$17M |
|
850
Preferred Bank
PFBC
$1.26B
| $19.9M | 0.03% |
373,057
+26,002
| +7% | +$1.34M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.